🎙️🫀 The Asymptomatic Aortic Stenosis Dilemma: Act Early or Wait Carefully, 🧠 Experts Differ

🔍 Two influential viewpoints just dropped in JAMA Cardiology on aortic valve replacement (AVR) in asymptomatic severe aortic stenosis (AS).   🫀 Lindman, Braunwald & Pellikka argue that the time has come to move from "watchful waiting" to early intervention (SAVR/TAVR), citing RCTs showing reduced stroke, heart failure hospitalization, and unplanned CV events.   ⚖️ Hillis, McCann & Newby counter that the evidence is not yet strong enough for a universal shift—pointing to trial limitations, competing risks in older patients, and the danger of unnecessary procedures.   ✨ The debate is clear: Act early or wait carefully? This conversation is shaping the future of valve guidelines and clinical practice.